Market Movers

McKesson Corporation’s Stock Price Skyrockets to $558.89, Marking a Robust 1.75% Uptick

McKesson Corporation (MCK)

558.89 USD +9.63 (+1.75%) Volume: 1.04M

McKesson Corporation’s stock price soars to $558.89, marking an impressive +1.75% increase within the trading session on a volume of 1.04M, reflecting a robust YTD performance with a surge of +20.72%.


Latest developments on McKesson Corporation

Today, Mckesson Corp. experienced a dip in its stock performance compared to its competitors. This drop comes after the company’s Executive Vice President and Chief Human Resources Officer decided to sell shares worth over $390k. Investors may be reacting to this significant insider activity, which could be influencing the stock price movements for Mckesson Corp. as of today.


McKesson Corporation on Smartkarma

Analysts at Baptista Research on Smartkarma have been closely monitoring Mckesson Corp‘s performance and growth across different segments. In a recent report titled “McKesson Corporation: How Is The Revenue and Profit Growth Across Segments Expected To Evolve? – Major Drivers,” they highlighted the company’s strong financial year in the Fourth Quarter Fiscal 2024. With consolidated revenue increasing by 12% to $309 billion and adjusted earnings per diluted share rising by 6% to $27.44, Mckesson Corp exceeded initial expectations. The analysts credited this growth to the company’s innovative solutions, quality commitment, and operational excellence.

Another report by Baptista Research, titled “McKesson Corporation: Anticipated Revenue Growth in Medical-Surgical Solutions Could Propel Them Forward! – Major Drivers,” focused on the company’s robust fiscal third-quarter earnings. With total revenues of $80.9 billion and adjusted earnings per diluted share of $7.74 showing double-digit growth year over year, Mckesson Corp continues to demonstrate momentum. The analysts emphasized the company’s focused execution against long-term priorities as the key driver behind this strong financial performance.


A look at McKesson Corporation Smart Scores

FactorScoreMagnitude
Value0
Dividend2
Growth4
Resilience5
Momentum4
OVERALL SMART SCORE3.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

McKesson Corp’s long-term outlook appears promising based on the Smartkarma Smart Scores. With high scores in Growth, Resilience, and Momentum, the company is well-positioned for future success. The Growth score indicates potential for expansion and development, while the Resilience score suggests the company’s ability to withstand challenges. Additionally, the Momentum score reflects the company’s current positive trajectory, pointing towards continued growth in the future.

Although McKesson Corp may not score as high in terms of Value and Dividend, its strong performance in other areas bodes well for its long-term prospects. As a distributor of pharmaceuticals and healthcare products, as well as a developer of healthcare software, McKesson plays a crucial role in the North American healthcare industry. With a focus on data integration and patient solutions, the company is well-positioned to continue its growth and innovation in the coming years.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars